The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)
Bibliography: International Policy Issues
Mapping prevention systems in the European Neighbourhood Policy area: a baseline for future monitoring and responses
This briefing describes the rationale and methodology of the prevention system mapping, presenting selected findings and highlighting key challenges encountered (EMCDDA)
World Drug Report 2022
Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability (UNODC)
European Drug Report 2022: Trends and Developments
European Drug Report 2022: Trends and Developments (EMCDDA)
European Drug Report 2022: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)
EU Drugs Agency: Council adopts negotiating mandate on strengthening the role of the agency
To step up the fight against illegal drugs, the Council today adopted its negotiating mandate on the proposal on the EU Drugs Agency, meant to turn the existing European Monitoring Centre for Drugs and Drug Addiction into a fully fledged agency and strengthen its role
Civil society monitoring of harm reduction in Europe 2021 data report
This is the third and last civil society-led C-EHRN Monitoring Report which is produced within the framework of the Operating Grant of the EU Health Programme1 (2018-2021). It is time to stand still and look at what we have achieved so far, what still needs to be done and where we see room for improvement (Correlation – European Harm Reduction Network)
High societies: International experiences of cannabis liberalisation
Across the world, approaches to cannabis regulation are changing. This report reviews evidence from jurisdictions that have liberalised cannabis, assessing how they have impacted health, crime, and economic outcomes, comparing them against the UK’s prohibition regime (Social Market Foundation)
Prisons and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide (EMCDDA)
Penalties for drug law offences in Europe at a glance
Examine and compare the penalties, or rehabilitative responses, for the core offences of drug use, possession for personal use, and supply-related offences, across countries in Europe (EMCDDA)
Reports published by the International Narcotics Control Board for 2021
Narcotic Drugs: Estimated World Requirements for 2022 — Statistics for 2020 (E/INCB/2021/2)
Psychotropic Substances: Statistics for 2020 — Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2021/3)
Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2021 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2021/4)
Death Penalty For Drug Offences: Global Overview 2021
This report, our eleventh on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international law (Harm Reduction International)
Major changes ahead for EMCDDA as it embarks on new work programme
This is our top commitment for the period 2022–2024 and we know that we can count on our European partners to deliver on this ambitious promise – download (EMCDDA)
(Re)framing regime performance: A critique of the INCB report for 2020
In this report, IDPC and the Global Drug Policy Observatory take a critical look at the narratives that the UN drug control system constructs to justify its own existence, and to create an appearance of success (idpc)
Commission proposes stronger mandate for EU Drugs Agency as illicit market proliferates
The Commission is proposing today to strengthen the mandate of the European Monitoring Centre for Drugs and Drug Addiction, transforming it into the European Union Drugs Agency (European Commission)
Summary of assessments, findings and recommendations of the 44th World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD)
11–15 October 2021
Pathways into, through and out of Residential Rehabilitation in Scotland
Results from the Residential Rehabilitation Providers Survey
Synthetic Drug Strategy 2021-2025
The UNODC Synthetic Drug Strategy presents a framework for action to address this global problem (UNODC)
Afghan opiates supply 8 out of 10 opiate users worldwide
The opium harvest in Afghanistan increased by eight per cent in 2021 compared to last year, to 6,800 tons, which could lead to markets around the globe being flooded with around 320 tons of pure heroin trafficked from the country – report (United Nations Office on Drugs and Crime)
Global Drug Policy Index
The Global Drug Policy Index provides each country with a score and ranking that shows how much their drug policies and their implementation align with the UN principles of human rights, health and development
- 1
- 2
- 3
- …
- 14
- Next Page »
